Moreover, T-VEC can induce PD-1 expression in tumor cells, making them susceptible for ICI and viral GM-CSF, and chemokine release can lead to attraction and maturation of APCs that can cross prime CD8+ TIL in anti-tumor response. Here, CD8A is linked to neoplasm.